Contractile smooth muscle-like peritubular cells build the wall of seminiferous tubules in men. They are crucial for sperm transport and complement the functions of Sertoli cells by secreting factors, including glial cell line-derived neurotrophic factor. Previous studies revealed that they also secrete the chemokine C-X-C motif chemokine ligand 12 (CXCL12), which has known roles in spermatogenesis. Peritubular cells express the androgen receptor (AR), which is retained in isolated human testicular peritubular cells. We aimed to explore AR-regulated functions in human testicular peritubular cells. Bearing in mind that infertile men often have high aromatase activity, which may lower intratesticular androgen concentrations, an animal model for male infertility was studied. These mice display an age-dependent loss in spermatogenesis due to high aromatase activity. Human testicular peritubular cells were exposed to dihydrotestosterone or the antiandrogen flutamide. We studied AR, smooth muscle cell markers, glial cell line-derived neurotrophic factor and 15 secreted factors previously identified, including CXCL12. We used qPCR, Western blotting, ELISA or selected reaction monitoring (SRM). In the animal model for male infertility, we employed qPCR and immunohistochemistry. Dihydrotestosterone increased AR and flutamide prevented these actions. The smooth muscle cell markers calponin and smooth muscle actin were likewise increased, while cell size or cellular proliferation was not changed. Dihydrotestosterone did not increase glial cell line-derived neurotrophic factor or CXCL12 secretion but increased levels of serine proteinase inhibitor (SERPIN) E1. The animal model for male infertility with high aromatase activity showed reduced numbers of AR-immunoreactive testicular peritubular cells, suggesting that altered androgen and/or oestrogen levels could influence AR-mediated responses in peritubular cells. Androgens act on human testicular peritubular cells to enhance AR levels, their contractile phenotype and to modulate the secretion of some secreted factors. This study suggests that some aspects of human peritubular cell functions are regulated by androgens.
INTRODUCTION
Thin, elongated smooth muscle-like cells form the wall of the seminiferous tubules in the adult testis together with extracellular matrix (ECM) (Maekawa et al., 1996) . These testicular peritubular cells (TPCs) are not well explored to this day, especially in man, where they form a rather complex, multilayered compartment, which contrasts to the simpler situation, that is only one cell layer and minute amounts of ECM, in most laboratory rodent species.
TPCs have important roles in testicular function (Wang et al., 2009; Nurmio et al., 2012; Svingen & Koopman, 2013; Flenkenthaler et al., 2014; Landreh et al., 2014) . A seminal function of adult TPCs is related to their smooth muscle-like nature, that is to contract and relax and thereby to transport immotile spermatozoa. TPCs are thus considered to be important for male fertility (Romano et al., 2005; Welter et al., 2013 Welter et al., , 2014 .
However, TPCs are also secretory cells and some of these products, namely ECM components, are involved in structural functions. Other products, for example growth factors, are capable to modulate testicular functions, including immune functions and spermatogenesis (Schell et al., 2008; Spinnler et al., 2010; Flenkenthaler et al., 2014; Welter et al., 2014; Mayer et al., 2016) . Specifically, human TPCs (HTPCs), as well as TPCs of mice, produce and constitutively release glial cell line-derived neurotrophic factor (GDNF) ( Spinnler et al., 2010; Chen et al., 2014 Chen et al., , 2016 . GDNF is also produced by Sertoli cells and is crucial for the renewal of spermatogonial stem cells (SSCs) . Elegant knockout studies in mice revealed the specific contribution of TPC-derived GDNF. The mice, while initially fertile, became infertile after two matings. This study showed that the undifferentiated spermatogonial pool of the murine testis cannot be maintained without GDNF from TPCs (Chen et al., 2016) . Hence, in this respect, TPCs significantly complement the roles of Sertoli cells in the formation of a functional spermatogonial stem cell niche. In addition, HTPCs secrete a plethora of factors including the chemokine C-X-C motif chemokine ligand 12 (CXCL12) (Flenkenthaler et al., 2014) , which also plays roles in the regulation of the SSC niche (Westernstroer et al., 2015; Niu et al., 2016) , but is not well examined in the human testis (McIver et al., 2013) .
How the functions of TPCs are regulated is not well known, but androgens are likely to be involved. Studies in mice, in which the AR was deleted in TPCs (PMT-ARKO), led to important insights (Welsh et al., 2009 (Welsh et al., , 2012 . While the development of the reproductive tract was normal, adult mutant males were azoospermic and infertile. This occurred without changes in testosterone levels, but certain functions of Sertoli cells and Leydig cells were impaired and the expression levels of androgendependent genes were reduced in PTM-ARKO males. TPCs, therefore, likely interact with other somatic cells of the testis presumably via secreted factors. GDNF may be such a factor, because GDNF production by murine TPCs was stimulated by androgens (Chen et al., 2014) .
The changes observed in the PMT-ARKO mice included alterations of the smooth muscle-like phenotype of TPCs (Zhang et al., 2006; Welsh et al., 2009 ). An age-dependent, progressive decrease in immunoreactive desmin (intermediate filament type of smooth muscle) and smooth muscle actin (SMA) occurred. While specific contractile proteins were not examined, this may reflect an androgen-dependent loss of the smooth muscle phenotype, resulting in an impaired ability to contract.
In man, immunohistochemical studies revealed a striking reduction or even loss of contractility markers of TPCs in cases of male infertility (Schell et al., 2010; Welter et al., 2013 Welter et al., , 2014 . This reduction was so far ascribed to the action of local intratesticular factors including a prostaglandin metabolite or reactive oxygen species (ROS). This prostaglandin metabolite is present in the testes of infertility patients and in a reversible manner caused dedifferentiation of isolated cultured human HTPCs (Schell et al., 2010) . Whether androgens or rather a lack of androgens may be involved, is not known.
We found that cultured HTPCs, stemming from explant cultures of small testicular fragments (Albrecht et al., 2006; Schell et al., 2010; Landreh et al., 2014) , retain AR expression in vitro. This allows one to explore androgen actions in this particular human cell type.
In addition, we also studied a mouse model for male infertility with low intratesticular testosterone, yet high intratesticular estradiol, namely transgenic males overexpressing P450 aromatase (AROM+) (Li et al., 2006; Strauss et al., 2009) . This model is of interest, as men with severely defective sperm production often also have excess aromatase activity (Schlegel, 2012) . Effective treatment of infertile men with aromatase inhibitors (namely testolactone, anastrazole and letrozole) has been shown to result in increased sperm production (Schlegel, 2012) . We examined AR, CXCL12, GDNF and contractility markers in AROM+ testes.
MATERIALS AND METHODS
Isolation, culture and treatment of human testicular peritubular cells Culture of isolated HTPCs from patients with normal spermatogenesis was performed as previously published (Albrecht et al., 2006; Schell et al., 2008; Adam et al., 2011) . The patients granted written informed consent and the local Ethical Committee has approved the study. The cells were treated with 100 nM, 1 lM and 10 lM dihydrotestosterone (DHT, Sigma Aldrich, St. Louis, MO, USA) for three days. Cells were pre-incubated for 30 min with 50 lM flutamide (Tocris, Bristol, UK), when used in combination with 10 lM DHT. Ethanol (Merck, Darmstadt, Germany), used as solvent for DHT and flutamide, was included as control in all experiments. Cell size and numbers were analysed using CASY, as described previously (Schell et al., 2010) .
Mouse model
In this study, a transgenic mouse line expressing human P450 aromatase under the control of the constitutive ubiquitin C promotor (AROM+) (Li et al., 2004 (Li et al., , 2006 was used. AROM+ mice, which are originally in FVB/N genetic background, were backcrossed to C57BL background for two generations. Thus, AROM+ mice in FVB/N X C57BL hybrid background were used in this study. The advantage of the hybrid to FVB/N background is that in the hybrid most AROM+ males are not cryptorchid, whereas AROM+ mice in FVB/N background are practically all cryptorchid. For this study, only non-cryptorchid mice were selected to avoid the consequences of cryptorchidism to the testicular phenotype. The mice were fed with soy-free natural ingredient food pellets (Special Diets Services, Witham, UK) and tap water ad libitum. They were housed in specific pathogen-free conditions at Central Animal Laboratory, University of Turku (Finland). The animals were handled in accordance with the Finnish Animal Ethics Committee and the Institutional animal care policies of the University of Turku, which fully meet the requirements as defined in the NIH Guide for the care and use of laboratory animals. Testes of transgenic and age-matched wild-type mice (4 months) were fixed, embedded in paraffin and used for immunohistochemistry.
RNA isolation of mouse testis and quantitative real-time RT-PCR (qPCR)
Total RNA was isolated from mouse testes using TRIsure reagent according to the manufacturer's instructions (Bioline Reagents Ltd., London, UK). 1 lg of total RNA was treated with deoxyribonuclease I (DNase I) Amplification Grade Kit (Invitrogen Life Technologies, Paisley, UK) and RT-PCR was carried out using the DyNAmo cDNA synthesis kit (Thermo Scientific, Waltham, MA, USA). The cDNA was diluted 1:100 and quantitative PCR was performed using the QuantiFast SYBR Green PCR Kit (Qiagen, Hilden, Germany). Samples were analysed in duplicates at an annealing temperature of 60°C in a LightCycler â 96 System (Roche Diagnostics, Penzberg, Germany). Primer sequences (designed using http://primer3.wi.mit.edu, synthesized by Metabion, Munich, Germany) and amplicons are depicted in Table 1 . Amplicon identity was confirmed via agarose gel electrophoresis and sequencing (GATC, Konstanz, Germany). Ribosomal protein Rpl19 was used as endogenous control to equalize for the amount of RNA in each sample, respectively. Data are depicted as relative to the corresponding age-matched wild-type mice.
RNA isolation of human HTPCs, RT-PCR and qPCR Total RNA was harvested from HTPCs, using Qiagen RNeasy Mini Kit (Qiagen), and was then reverse transcribed using dN12 random primers. This was followed by PCR for AR using an annealing temperature of 58°C. Amplicon identity was confirmed by gel electrophoresis and sequencing (GATC). The qPCR method for human AR, GDNF and CXCL12 was performed as described previously (Welter et al., 2014) (Abcam, Cambridge, UK; # ab46794; 1: 2000) , and against human SMA (Sigma Aldrich; # A5228; 1: 500), were used and applied as described in previous studies (Frungieri et al., 2000) . The stained proteins were quantified densitometrically (NIH-Image J 1.42 q) and results normalized to beta-actin (Sigma Aldrich; 1: 5000) serving as loading control (Schell et al., 2010) .
Immunohistochemistry and evaluation of AR-immunopositive cells
For immunohistochemical purposes (Schell et al., 2010) , three human testicular biopsies of men with normal spermatogenesis were stained with the antibody against AR (1: 250) also used for Western blot studies. Negative controls included rabbit IgG and mouse IgG1 isotype as well as omission of the primary antibodies. To visualize cellular details, some samples were counterstained with haematoxylin. For the immunostaining of mouse samples, we used a rabbit polyclonal antibody against AR (Santa Cruz Biotechnology, Heidelberg, Germany; # sc-816; 1:50-1:500). Negative controls included rabbit IgG or omission of the primary antibody. Two observers independently evaluated the results of AR-immunohistochemistry in testis of AROM+ and WT mice (n = 3/group). Slides were examined under a microscope coupled to a digital camera. Colour microscopic images were recorded using the 209 objective in six microscopic fields corresponding to an average of 37 (AE8) seminiferous tubules. The numbers of positively stained peritubular cells were presented as mean value per tubule, and immunopositive Sertoli cells were excluded from the cell counts. In addition, tubule diameters were determined in the same samples used for immunohistochemistry (30 tubules/mouse testis).
ELISA
ELISA-measurement of CXCL12 (R&D Systems, Minneapolis, MN, USA) was carried out according to the manufacturer's instructions. The CXCL12 levels were measured in the culture supernatant after 72 h treatment with 10 lM DHT in DMEM without phenol-red containing 5% FCS and 1% penicillin/streptomycin. The detection range of this assay was 156.0-10,000 pg/ ml. GDNF levels in the culture supernatants were also measured after 72 h, as previously described (Spinnler et al., 2010; ReyAres et al., 2018) . Results were normalized to the protein amounts (DC Protein Assay Kit, Bio-Rad Laboratories GmbH, Munich, Germany) of the cell homogenates.
Statistics
Results were analysed statistically using GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). The effects of different treatments on Western blot were calculated using One-Way Analysis of Variance and all following pairwise multiple comparison procedures by Newman-Keuls test. Results derived from qPCR of HTPCs were calculated with paired t-tests. In the transgenic mouse model, unpaired t-tests (two-tailed) of -DDCq values were performed to investigate differences in mRNA expression. Other results, including cell counting data, evaluation of testes weights and tubule diameters, were evaluated using Student's t-test. All data are expressed as mean + SEM (standard error of the mean). p < 0.05 was considered significant (*) and p < 0.01 highly significant (**).
Sample preparation for SRM quantification
Serum-free conditioned media of HTPCs from six patients after 72 h treatment with 10 lM DHT or ethanol were collected and concentrated on 3 kDa molecular weight cut-off filters (Millipore, Schwalbach, Germany), as described previously (Flenkenthaler et al., 2014) . The samples are derived from the same HTPCs that were used for ELISA studies. Concentrated samples were dissolved in denaturation buffer (8 M Urea, 50 mM ammonium bicarbonate) and protein concentrations were determined using the Pierce 660 nm Protein Assay (Thermo Scientific, Rockford, IL, USA). 10 lg of protein was reduced in 4 mM dithiothreitol (DTT)/2 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) for 30 min at 56°C, and alkylated with 8 mM iodoacetamide (IAA) for 30 min in the dark. Residual IAA was quenched using DTT at a final concentration of 10 mM. Protein samples were digested in a first step with Lys-C (1 : 100, enzyme:substrate; Wako, Neuss, Germany) for 4 h at 37°C, diluted with 50 mM ammonium bicarbonate to a concentration of 1 M urea, followed by digestion with porcine trypsin (1 : 50, enzyme : substrate; Promega, Madison, WI, USA) overnight at 37°C. Peptide samples were dried using a vacuum concentrator (Bachofer, Reutlingen, Germany) and stored at À80°C until SRM analysis.
SRM assay development
Selected reaction monitoring (SRM) has become a popular method in the field of proteomics over the last decade and represents a mass spectrometry-based technology for the targeted quantification of proteins (2013 , Gillette & Carr, 2013 Lange et al., 2008; Meyer & Schilling, 2017; Percy et al., 2016) . Basically, the targeted proteins are quantified by monitoring a set of predefined precursor/fragment ion pairs ('transitions') of corresponding proteotypic peptides in an SRM experiment (Frohlich & Arnold, 2011; Picotti & Aebersold, 2012) . We employed this method in our study and selected proteins based on a previous analysis of the HTPC secretome (Flenkenthaler et al., 2014) . CXCL12 and HTPC-secreted factors, which potentially contribute to the spermatogonial stem cell niche, were selected. Further information is provided in Table S1 . Relative quantification of CXCL12 was conducted within a multiplex scheduled SRM assay, allowing the parallel measurement of 26 peptides representing 15 proteins within the same LC-MS run. Representative for CXCL12, two proteotypic peptides (FFESHVAR, ILNTPNC [CAM]ALQIVAR) were selected based on experimental evidence 758 Andrology, 2018, 6, 756-765 (Flenkenthaler et al., 2014) and public databases, including and SRMAtlas . Corresponding stable isotope (SI)-labelled peptides (crude PEPotec SRM peptides, Thermo Scientific, Rockford, IL, USA) were used as internal standards for relative quantification. The amount of internal standard peptides, which were equally added to each sample, was adjusted to closely match the levels of the endogenous counterparts. The three most intense, selective and reproducible transitions per peptide were selected, and optimized regarding their collision energies for the final SRM assay.
LC-SRM-MS analysis
LC-SRM-MS analyses were performed on a nanoACQUITY UPLC system (Waters, Milford, MA, USA) coupled to a triplequadrupole linear ion trap mass spectrometer (QTRAP 5500, AB SCIEX, Framingham, MA, USA). 1 lg of peptide was loaded on a trap column (PepMap100 C18, 5 lm, 300 lm i.d. 95 mm, Thermo Scientific) at a flow rate of 10 ll/min and separated at a flow rate of 280 nl/min on a reversed-phase C18 nano-LC column (ReproSil-Pur 120 C18-AQ, 2.4 lm, 75 lm i.d. 915 cm, Dr. Maisch, Ammerbuch-Entringen, Germany) in consecutive linear gradients: 1-5% B (0.1% formic acid in acetonitrile) in 1 min, 5-35% B in 45 min and 35-85% B in 5 min. The QTRAP mass spectrometer was operated in positive ionization mode using a needle voltage of 2.5 kV. In total, 156 transitions from 26 peptides representing 15 proteins, with each light and heavy counterparts, were monitored in a single multiplex scheduled SRM method within a detection window of 8 min and a cycle time of 2 s during the LC gradient.
SRM data analysis
SRM raw files from each sample were analysed in Skyline (v. 3.7.0.10940) (MacLean et al., 2010) . Statistical relative quantification was performed using the R package MSstats (v. 3.8.2) (Choi et al., 2014) as an external tool within Skyline. For relative quantification, peak areas of SI-labelled peptides were used to normalize peak areas of the corresponding unlabelled endogenous peptides. Linear mixed models were used for the determination and statistical evaluation of differential protein abundance. Differences were considered to be significant with a probability value of p < 0.05 in pair-wise comparisons (Student's t-test) . Quantification values were depicted as fold change relative to control samples. GraphPad Prism (v. 5.04, GraphPad Software, La Jolla, CA, USA) was used for visualization of differential protein abundance.
RESULTS
Immunoreactive AR in human testes with normal spermatogenesis was readily observed in the nuclei of peritubular cells, Sertoli cells and in interstitial cells. No labelling was detected, when the AR antibody was replaced by rabbit IgG (Fig. 1A) . AR was also readily detected in cultured HTPCs as shown by Western blot analysis, yielding a single band, and by RT-PCR studies (Fig. 1B) .
DHT treatment of HTPCs (100 nM, 1 lM, 10 lM) for three days led to a concentration-dependent increase in AR protein levels as observed in Western blot analyses ( Fig. 2A) . Quantitative RT-PCR of AR transcripts revealed a significant increase in mRNA expression by a DHT (10 lM) treatment for three days (Fig. 2B) . Furthermore, flutamide (50 lM), added 30 min before DHT stimulation, prevented the DHT-mediated increase in AR protein (Fig. 2C) .
Treatment of HTPCs (isolated from three patients) for three days with different concentrations of DHT (100 nM, 1 lM, 10 lM) also increased the protein levels of calponin, a protein important for smooth muscle cell contractility, previously described in HTPCs . A significant increase was shown with the highest concentration of DHT compared to controls in samples of six different patients (Fig. 3A ). An antiandrogen treatment with flutamide prevented this increase (Fig. 3B) . Smooth muscle actin (SMA) levels in HTPCs were likewise increased by DHT and in this case, all tested concentrations of DHT significantly increased SMA levels in treated over control cells in samples of four different patients (Fig. 3C) . We examined whether the DHT actions were due to changes in cell number or the viability of the HTPCs. A highly effective concentration of DHT (10 lM) added to HTPCs for three days did, however, not influence the size of HTPCs or their number, indicating that DHT affects specifically the smooth muscle phenotype of HTPCs (n = 3 patients/group; Fig. 4A,B) .
HTPCs secrete GDNF (Spinnler et al., 2010) and when DHT was added for three days to HTPCs, we did not observe changes in GDNF mRNA (n = 4 individual donor-derived HTPCs) or protein accumulation in the cell culture supernatant when samples from six donors were examined (Fig. 4C) . To exclude technical errors with the experiments, we also used the cell pellets and verified AR expression by Western blotting.
The results showed that in all samples, DHT increased AR levels (not shown).
A proteomic study had identified CXCL12 as a secreted factor of HTPCs (Flenkenthaler et al., 2014) . To examine whether DHT may influence secretion, we performed an exploratory SRM study and subsequent ELISA measurements. Relative quantification of CXCL12 was performed within a 26-plex scheduled SRM assay representing 15 proteins. Protein selection emerged from previous studies on the HTPC secretome (Flenkenthaler et al., 2014) and contained, besides CXCL12, HTPC-secreted factors that potentially contribute to the composition and maintenance of the spermatogonial stem cell niche in man. More information on the rationale for protein selection including their potential function in the regulation of testicular function and spermatogenesis is provided in Table S1 . A full list of the monitored transitions including SRM parameters can be found in Table S2 . Quantification results suggested a slight but not significant increase for CXCL12 (log2 fold change: 0.51, paired t-test, p = 0.038) and a strong increase for SERPIN E1 (log2 fold change: 0.72, p = 0.002) in samples from six donors treated with DHT (Fig. 4D) . Relative abundance profiles of the two targeted CXCL12 peptides can be found in Figure S1 . Processed data used for statistical analysis and summarized quantification results for the 15 target proteins are provided in Tables S3 and S4 . Subsequent ELISA and qPCR measurement taken in five samples showed that CXCL12 is not robustly increased by DHT and a small increase became apparent in three of five samples examined (Fig. 4C) . The AROM+ mouse provides an in vivo model, in which consequences of low intratesticular androgen levels can be studied in the presence of increased intratesticular estradiol (Li et al., 2004 (Li et al., , 2006 . With increasing age, this imbalance leads to impaired spermatogenesis. At an age of four months, testicular weights are not yet different between AROM+ and WT mice and spermatogenesis is still continuing (Fig. 5A) . However, in line with the previous studies (Li et al., 2004 (Li et al., , 2006 , some changes became obvious in the interstitial compartment (e.g. number of macrophages and Leydig cell hypertrophy). In whole testes, we did not observe statistically significant changes in Gdnf, Cxcl12 or Sma levels in four months old AROM+. A trend to lower Ar was evident, which was, however, not statistically significant (Fig. 5C ).
Immunoreactive AR was qualitatively similar in AROM+ and WT and observed in Sertoli cells and TPCs (Fig. 5A) . Most but not all nuclei of TPCs were immunopositive. Evaluation of ARimmunopositive TPCs, however, revealed significantly fewer immunoreactive TPCs in AROM+ testes compared to WT testes (Fig. 5B) . The tubule diameters were unchanged between the two groups ( Figure S2 ). No labelling was detected when rabbit IgG isotype was used instead of the primary antibody.
DISCUSSION
Contractile activities of smooth muscle-like HTPCs are responsible for the transport of spermatozoa and these cells further contribute to the SSC niche via secreted factors (Maekawa et al., 1996; Wang et al., 2009; Nurmio et al., 2012; Svingen & Koopman, 2013) . Using HTPCs from adult men, we found that androgen treatment positively affected the smooth muscle phenotype of adult HTCPs but did not significantly influence the basal secretion levels of GDNF and CXCL12. In addition, androgen treatment elevated SERPIN E1 secretion. DHT treatment increased AR mRNA expression and promoted an up to fourfold increase in AR protein in HTPCs. Therefore, androgen action on HTPCs likely enhances androgen-dependent responses, which could in turn increase the contractile phenotype of these cells.
A crucial role of androgens in the smooth muscle cell-like differentiation of testicular peritubular cells was suggested by previous studies with knockout mouse models (Zhang et al., 2006; Welsh et al., 2009) . Insights into the specific human testicular situation became possible upon the establishment of a technique to culture HTPCs, that is cells derived from adult men Flenkenthaler et al., 2014) . AR and smooth muscle cell protein expression is retained when HTPCs, obtained from adult men, are cultured in the absence of androgens. This is in line with previous observations in non-human primate (Schlatt et al., 1993) . The current study shows that upon addition of DHT, calponin, SMA and AR levels were elevated. The AR was specifically involved and initiated these changes, as shown by the data with the antiandrogen, flutamide. Thus, the phenotype of HTPCs, derived from adult men, can be modulated and androgen treatment entails an enhancement of the cellular phenotype towards a smooth muscle phenotype. These findings are consistent with the proposition that androgens in the human testis modulate the smooth muscle-like phenotype of HTPCs, which could in turn mediate contractility and sperm transport through the seminiferous tubules (Palombi et al., 2002; Romano et al., 2005; Zhang et al., 2006; Welsh et al., 2009) .
In many cases, androgens downregulate the AR (Burnstein, 2005) . A positive autoregulation of the AR was, however, observed in HTPCs and androgen treatment entailed increased expression of AR. A positive autoregulation of AR by androgens has also been reported for bone (Takeuchi et al., 1994; Wiren et al., 1997) , rodent prostate (Takeda et al., 1991) and heart (Golden et al., Figure 3 DHT increased calponin and SMA in cultured HTPCs. (A) DHT treatment (100 nM, 1 lM, 10 lM) for three days led to a significant increase in protein levels of calponin. Examples of Western blot bands are depicted above and results normalized to b-actin and expressed relative to controls are shown below. (B) DHT increased the level of calponin, whereas flutamide reduced AR levels (three days). An original Western blot is shown. The experiment was performed twice and yielded similar results. (C) SMA protein levels were likewise significantly increased by DHT in all tested concentrations. Examples of Western blot bands are depicted above and results normalized to b-actin and expressed relative to controls are shown below. The number of HTPCs derived from individual patients is indicated in the columns. Data show mean + SEM. *p < 0.05 was considered statistically significant. Le et al., 2014) . In case of rat peritubular cells, isolated from 20-day-old animals, testosterone had no effect or slightly decreased AR mRNA in Sertoli and peritubular cells (Sanborn et al., 1991) . The HTPC results give credence to the idea of species-and tissue-specific regulation (Coffey & Robson, 2012) .
2002;
In the human prostate, androgens promote cell growth of stromal and epithelial cells, thereby fostering the development of benign prostate hyperplasia (Izumi et al., 2013) . In our study, however, treatment by DHT did not promote proliferation or affect the viability of HTPCs.
Previously, a stimulatory, albeit slight influence of DHT on the mRNA levels of pigment epithelium-derived factor, PEDF, a multifunctional protein and a secreted product of HTPCs, was found (Windschuttl et al., 2015) . PEDF is also known as Serpin F1, and the SRM results indicate that its secretion was not significantly altered by DHT, at least under the experimental conditions. We did not further study this factor, but rather turned to a factor directly involved in the regulation of SSC, namely GDNF. It is a product of Sertoli cells and TPCs (Chen et al., 2016) , including HTPCs (Spinnler et al., 2010) . The importance of GDNF, derived from TPCs, was revealed in a TPC-specific knockout mouse model (Chen et al., 2016) . In isolated murine TPCs, androgen stimulation increased the secretion of GDNF (Chen et al., 2014) . In contrast, when we added DHT to HTPCs, we did not observe significant changes in the GDNF protein or mRNA levels. The cells tested were, however, responsive to DHT, in general, as witnessed by increased AR expression. GDNF was described as a constitutively secreted factor of HTPCs (Spinnler et al., 2010) . DHT did not modulate GDNF production by HTPCs in vitro, suggesting that, unlike in mice, human peritubular cell GDNF production may not be androgen-dependent.
Human Sertoli cells produce CXCL12 (McIver et al., 2013) , which is being implicated in the SSC niche, as well. A proteomic study had identified CXCL12 also as a secreted factor of HTPCs (Flenkenthaler et al., 2014) . We performed studies to examine a possible regulation by DHT. The statistical evaluation of the very sensitive SRM technique indicated such an increment of CXCL12, which was, however, small. ELISA measurements showed small increases as well, albeit only in three of five samples, implying a donor-specific mode of actions. The results suggest that the production of this factor in human peritubular cells is not androgen-dependent.
SRM results showed, however, that the androgen treatment is linked to a strong upregulation of SERPIN E1, encoding plasminogen activator inhibitor-1. This is the principal inhibitor of tissue plasminogen activator and urokinase and it was found previously in peritubular cells of the rat, as well as in Sertoli cells (Nargolwalla et al., 1990) . The specific roles for this protein in the human testis remain to be studied. A hormonal regulation by testosterone in endothelial cells was reported (Jin et al., 2007) .
Other proteins, including BGN or PTX3, which were implicated in immunological roles of HTPCs (Mayer et al., 2016) , were not statistically significantly affected. Figure 4 Actions of DHT on cell number, size and secreted factors of cultured HTPCs. (A, B) Results of automated determination of cell number and size (CASY) using HTPCs from three patients. Cells were treated with DHT (10 lM) for three days. Results indicate that the cell number is not affected by DHT. (C) Results of GDNF and CXCL12 ELISAs performed with cell culture supernatant from HTPCs are shown after three days. Levels of GDNF between control and DHT treated samples did not change. GDNF mRNA levels were not affected by DHT. CXCL12 levels were increased in three of five donors, and CXCL12 mRNA expression was not altered by DHT treatment. The number of patients is indicated in the columns. Data show mean + SEM. (D) Volcano plot of relative protein abundance of 15 proteins quantified in a multiplex SRM assay. Positive log2 fold change indicates higher abundance with DHT treatment compared to controls (n = 6). To complement cellular studies in HTPCs, we turned to an animal model for male infertility, AROM+. AROM+ males develop age-dependent impairments of spermatogenesis, increased intratesticular metabolism of testosterone and hence lower intra-testicular androgens (Li et al., 2004 (Li et al., , 2006 Strauss et al., 2009 ). In the case of the five mice (AROM+ and WT) used for this study, measurement of sex steroids in the contralateral gonads indicated a mean of 74 AE 50 pg/mg (mean AE SD) testosterone in AROM+ and 656 AE 852 pg/mg in WT. Estradiol in the testes of AROM+ was 1.88 AE 1.85 pg/mg and 0.47 AE 0.67 pg/ mg. We found that these animals show a significantly lower number of AR-immunoreactive TPCs at the age of four months. As tubular diameter was unchanged, this is likely due to a reduced number of AR-immunoreactive cells and argues for changes that occur before spermatogenesis becomes markedly disrupted. Due to the inconspicuous nature of unstained, ARnegative nuclei of peritubular cells, they were not counted. At the time of observation testes, weights and contractile markers were still unchanged, as were CXCL12 and GDNF expression levels. Thus, low levels of androgens are correlated with low levels of AR in TPCs. This observation is in line with the cellular data, which showed that the levels of AR increase upon addition of DHT in HTPCs. Clearly, the changes could also be caused by increased estradiol levels and/or other androgen or oestrogendependent alterations in paracrine factors from the seminiferous tubules or interstitium. That the lower AR levels in mouse TPCs precede the progressive impairment of spermatogenesis that occurs later, suggests that AR-mediated actions of TPCs are crucially involved.
On this basis, our observations in AROM+ and our studies in HTPCs may shed light on the situation of some men with impaired spermatogenesis, in which a reduced smooth musclelike phenotype was obvious (Schell et al., 2010; Welter et al., 2013 Welter et al., , 2014 . Excess aromatase activity has been associated with severely defective sperm production in some infertile men (Schlegel, 2012) . Interestingly, treatment of such infertile men with aromatase inhibitors (namely testolactone, anastrazole and letrozole) has been shown to increase sperm production (Schlegel, 2012) . Although the mechanism of action is unclear, it may involve a reduction in negative oestrogen feedback within the hypothalamic-pituitary-gonadal axis (Schlegel, 2012) . Based on our study, a further or alternative mechanism is suggested, namely AR-dependent modulation of the cellular differentiation of HTCPs. It is possible that the resulting increased (testicular) levels of androgens in men treated with aromatase inhibitors may then lead to an enhanced smooth muscle differentiation and thus, enhance the functional activity of HTPCs.
HTPCs allow the partial exploration of the specific situation in the adult human testis. The present data identify androgen/AR signalling as crucial for the maintenance of the smooth muscle phenotype of HTPCs, which is important for male fertility. This insight may help to better understand testicular changes in male infertility and to may allow the development of new treatments.
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